Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Fine Lines: early-phase trial registry

2 of 7 indexed Fine Lines trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Fine Lines: 7 US clinical trials tracked, 2 recruiting.

Fine Lines is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Revision Skincare, running 4 of these trials.

Enrollment posture brief

Registry condition fine-lines

OPEN 2 | RECR 29% | LATE 0 | EARLY 2 | RANK #2497 | SPON 4

Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Fine Lines (this)29%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Fine Lines

Fine Lines lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fine Lines on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fine Lines is recruiting below its size-band peers.

    2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Fine Lines research.

    Revision Skincare accounts for 4 of 7 trials (57.1%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Fine Lines trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 7 trials that report a genuine target (sentinel values excluded). 7 of those (100%) plan for fewer than 100 participants.

  4. Fine Lines research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Top Sponsors

CERM 1 trials
Cynosure 1 trials
Krystal Biotech 1 trials

Named interventions

Most-linked intervention names on Fine Lines records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Facial Moisturizer Other
2 trials
Cleansing Lotion Other
1 trials
Anti-aging Serum Other
1 trials
Aveeno Face Milk SPF 40+ Other
1 trials
Gentle Cleansing Lotion, Revision Skincare Other
1 trials
Sunscreen SPF 30 Other
1 trials
Gentle Cleansing Lotion Other
1 trials
Sunscreen Combination
1 trials

US sites by state

Facility locations filed on Fine Lines trials. A trial with sites in several states counts in each.

Texas 2 trials
California 2 trials
New Jersey 1 trials
Massachusetts 1 trials
Florida 1 trials
Delaware 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fine Lines page

7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fine Lines condition card totals 7 registered trials; most-linked intervention Facial Moisturizer; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.